Clinical Trial: Biomarkers in Patients With Advanced Rhabdomyosarcoma

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Developmental Pathway Drug-Targets in Advanced Rhabdomyosarcomas

Brief Summary: This research trial studies tumor tissue to identify important proteins and biomarkers from patients with rhabdomyosarcoma that has spread to other places in the body and usually cannot be cured or controlled with treatment. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.